Sunday, March 31, 2013

Lightnings' Lindback On Injured Reserve

The bad news just keeps coming for the Tampa Bay Lightning.
The latest news is that goaltender Anders Lindback will be out indefinitely with a high ankle sprain.
Lindback took over the net for Mathieu Garon early in the second period during the game last Wednesday night against the Toronto Maple Leafs. Right after Radko Gudas scored his first NHL goal off Toronto goaltender James Reimer, Lindback skated off the ice and Garon reentered.
According to Tampa Tribune reporter Erik Erlendsson, who tweeted, "Lindback said he jammed his ankle sliding over to his post on Kadri's partial breakaway when the skate blade hit the post, he felt a pop."
The 24 year old 6-foot-6 Swedish goaltender was acquired by the Lightning in an off-season trade with the Nashville Predators. He has played 21 games so far this season and has a 10-7-1 record. His goals allowed average is 2.88 with a save percent of .903.
Coach Guy Boucher said of Lindback, "Our goaltender had really picked up his game. He was really showing us what we were hoping and expecting from him, and it was just starting to pay off; you could really feel it. So, one I feel bad for him. He's such a good kid and worked so hard to stabilize his game."
The Lightning will likely recall goaltender Cedrick Desjardin from the AHL affiliate Syracuse Crutch to play backup for Garon. The team is currently without three other starters due to injuries.
"It tough," center Steven Stamkos said. "A lot of good players we have injured. That's always something easy to say as an excuse, but we have some very impactful players that are out. When you look at it, it's tough to stay positive. It's tough to try to find good things."
Reference: Tampa Bay.Com and Sports Illustrated Bolts By the Bay
If you are a hockey player and have a foot problem, call our Newington, Kensington, or Middletown office to make an appointment.
Craig M. Kaufman, DPM
Connecticut Foot Care Centers
Sports Medicine Podiatrist in CT
Podiatrist in Newington
Visit our website, like our page on Facebook, and follow our tweets on Twitter

Enhanced by Zemanta

No comments:

Post a Comment